Clinical Study to Understand the Outcomes and Risk of Rare Brain and Spine Cancers
Clinical Study to Understand the Outcomes and Risk of Rare Brain and Spine Cancers
Senior Investigator Terri Armstrong, Ph.D., and Clinical Research Nurse Kathleen Wall share information about an online study available at NIH to help researchers better understand the outcomes and risk factors related to the occurrence of rare brain and spine tumors. They explain the goals of the study, who can participate and how, and what patients can expect.Learn more at: https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/risk-study.
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.